Key cellular enzyme could be effective drug target in urological cancer cells A key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney, new research indicates. Ongoing research into treatments for kidney cancer is especially important since kidney cancer is known to be resistant to current chemotherapy
Cancer preventative surgery could become a thing of the past Two new studies looking at the effect the menstrual cycle has on the development of breast and ovarian cancer reveal alternative prevention strategies that may render surgery unnecessary
Cancer patient receives 3-D printed ribs After being diagnosed with a chest wall sarcoma, a 54-year-old Spanish man's surgical team made the decision to remove his sternum and a portion of his rib cage and replace it with an implant. This cancer patient has now received a 3-D printed titanium sternum and rib implant.
New epigenetic study reveals exciting insights into colorectal cancer progression New epigenetic markers for colorectal cancer have been identified by researchers, suggesting that there may be a new approach for treatment in sight
Improving a better class of cancer drugs A class of therapeutic drugs known as protein kinase inhibitors has become a powerful weapon in the fight against various life-threatening diseases. One problem with these drugs, however, is that they often inhibit many different targets, which can lead to side effects and complications in therapeutic use. A recent study has identified a new technique for improving the selectivity of these drugs and possibly decreasing unwanted side effects in the future.